A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Clinical trial NCT07581951 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07581951
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

MASH - Metabolic Dysfunction-Associated Steatohepatitis NASH (Non-Alcoholic Steatohepatitis)

Start date: 2026-06-30
Primary completion: 2029-06-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.